# 血管内超声市场

> 血管内超声市场研究报告按应用（心脏病学、血管外科、肿瘤学、外周血管疾病）、按技术（标准血管内超声、射频血管内超声、光学相干断层扫描）、按最终用途（医院、门诊手术中心、诊断实验室）、按产品类型（导管、控制台系统、配件）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.04%
- **2024:** $ 2.65 Billion
- **2025:** $ 2.79 Billion
- **2035:** $ 4.56 Billion
- **Key Players:** Philips (NL), Siemens Healthineers (DE), GE Healthcare (US), Canon Medical Systems (JP), Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), Terumo Corporation (JP), B. Braun Melsungen AG (DE)

**Report ID:** MRFR/HC/30855-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/intravascular-ultrasound-market-32654

---

## Market Summary

## **Intravascular Ultrasound Market Overview**

As per MRFR analysis, the Intravascular Ultrasound Market Size was estimated at 2.65 (USD Billion) in 2024. The Intravascular Ultrasound Market Industry is expected to grow from 2.79 (USD Billion) in 2025 to 4.34 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.04% during the forecast period (2025 - 2034).

### **Key Intravascular Ultrasound Market Trends Highlighted**

The Intravascular Ultrasound Market is seeing significant growth driven by the increasing prevalence of cardiovascular diseases and the aging population. The demand for minimally invasive procedures is rising, as healthcare providers and patients recognize the benefits of reduced recovery times and lower risks of complications.

Additionally, advancements in ultrasound technology, such as enhanced imaging capabilities and integration with other diagnostic tools, are further propelling market growth. Healthcare professionals are increasingly adopting intravascular ultrasound for better visualization during coronary interventions, leading to improved patient outcomes. There are numerous opportunities to explore within this market, particularly with the ongoing development of innovative technologies. 

Emerging markets present a vast potential for growth, as healthcare systems are expanding and investing in advanced medical technologies. By focusing on research and development, companies can create new applications for intravascular ultrasound, making the technology more accessible and effective.

Collaboration with healthcare providers and integration with telemedicine can also open new avenues for growth, enhancing the adoption of intravascular ultrasound in various settings. Recently, the market has experienced trends such as a shift towards portable and user-friendly intravascular ultrasound systems that cater to both hospital and outpatient settings.

The rise of telehealth is influencing how these services are delivered, allowing for remote consultations and follow-ups. Additionally, the focus on personalized medicine is shaping the development of more tailored treatment options, which can further enhance the role of intravascular ultrasound in patient care.

Overall, the intravascular ultrasound market is evolving rapidly, influenced by technological advancements and changing healthcare dynamics, presenting various pathways for continued growth and innovation.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

### **Intravascular Ultrasound Market DrivAdvancements in Imaging Technology**

The Intravascular Ultrasound Market Industry is experiencing significant growth driven by advancements in imaging technology. The introduction of high-resolution imaging systems is one of the primary factors contributing to the expansion of this market. Enhanced imaging capabilities allow for more accurate assessments of coronary arteries, which are crucial for diagnosing and treating various cardiovascular conditions. 

These innovations have facilitated better visualization of the arterial walls and helped healthcare professionals identify plaque buildup and narrowing of the arteries, leading to improved patient outcomes.Furthermore, continual improvements in hardware and software technologies, including three-dimensional imaging and automated analysis tools, are revolutionizing the field.

Such enhancements not only streamline the diagnostic process but also enable more precise procedural planning. As medical professionals seek better diagnostic tools, the demand for advanced intravascular ultrasound systems continues to rise, making technological improvements a significant driver in the Intravascular Ultrasound Market Industry.

### **Rising Prevalence of Cardiovascular Diseases**

The increasing prevalence of cardiovascular diseases globally has emerged as a key driver in the Intravascular Ultrasound Market Industry. As the population ages and lifestyle-related health issues become more common, the demand for effective diagnostic and therapeutic options has surged.

Intravascular ultrasound provides detailed insights into cardiovascular conditions, helping to detect issues like arterial stenosis and plaque formation. This growing burden of cardiovascular diseases necessitates reliable and precise imaging modalities, thereby fueling market growth.

### **Growing Geriatric Population**

The rapid growth of the geriatric population worldwide is significantly influencing the Intravascular Ultrasound Market Industry. Older adults are at a higher risk of developing cardiovascular conditions, creating an increased demand for diagnostic tools capable of early detection and management. The rise in elderly patients emphasizes the need for advanced imaging technologies such as intravascular ultrasound, which can improve treatment planning and patient care.This demographic trend is expected to sustain market growth as healthcare systems adapt to cater to the needs of an aging population.

## **Intravascular Ultrasound Market Segment Insights**

### **Intravascular Ultrasound Market Application Insights ** 

The Intravascular Ultrasound Market is experiencing noteworthy growth, particularly within the Application segment, which plays a critical role in various medical fields. In 2023, the overall market was valued at 2.41 USD Billion, showing a solid foundation that is expected to expand significantly by 2032. The market can be broadly segmented into Cardiology, Vascular Surgery, Oncology, and Peripheral Vascular Disease, each contributing uniquely to the overall revenue.

Among these, Cardiology emerges as the dominant application area, boasting a valuation of 1.04 USD Billion in 2023 and projected to grow to 1.58 USD Billion by 2032. This segment's significant size underscores its importance in diagnosing and treating heart diseases, leveraging advanced imaging techniques to provide accurate insights during procedures.

In the next tier, Vascular Surgery is also prominent, with a valuation of 0.78 USD Billion in 2023, expected to reach 1.19 USD Billion by 2032. The increase in vascular intervention procedures drives this segment's growth as healthcare providers increasingly utilize intravascular ultrasound for real-time imaging and guidance.

Meanwhile, the Oncology segment, valued at 0.45 USD Billion in 2023, is projected to grow to 0.68 USD Billion by 2032. This indicates a rising trend toward utilizing intravascular imaging to improve diagnostics and treatment planning for cancer patients, highlighting its significance within the [radiation oncology](../../../reports/radiation-oncology-market-12350) sector.

Finally, the Peripheral Vascular Disease segment, while smaller, with a valuation of 0.14 USD Billion in 2023 and a projected growth to 0.30 USD Billion by 2032, is gaining traction due to the increasing prevalence of vascular diseases and the need for effective imaging solutions for these conditions.

The growth drivers across these applications include advancements in imaging technologies, rising incidences of cardiovascular and vascular diseases, and the growing preference for minimally invasive procedures. However, challenges may include high costs associated with intravascular ultrasound systems and the need for skilled personnel to operate these advanced equipment.

Nevertheless, opportunities are abundant, as ongoing research and development may lead to improved devices and techniques, thereby expanding the Global Intravascular Ultrasound Market's scope further. Consequently, understanding the Intravascular Ultrasound Market data and market growth across these applications aids in comprehending the broader trends influencing the industry as a whole.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

### **Intravascular Ultrasound Market Technology Insights  **

The Intravascular Ultrasound Market within the Technology segment was valued at 2.41 USD Billion in 2023 and is poised for significant growth as it moves towards an estimated value of 3.75 USD Billion by 2032. This segment includes various technologies such as Standard Intravascular Ultrasound, Radiofrequency Intravascular Ultrasound, and Optical Coherence Tomography.

Standard Intravascular Ultrasound is widely recognized for its reliability and accuracy, thus holding a major share of the market. Meanwhile, Radiofrequency Intravascular Ultrasound is gaining traction due to its capabilities in tissue characterization and treatment planning.

Optical Coherence Tomography is also significant as it offers high-resolution imaging, enhancing diagnostic capabilities. These technologies are critical as they aid in improved patient outcomes by facilitating better visualization of vascular structures during procedures. The increasing number of cardiovascular diseases, along with technological advancements, plays a vital role in driving the growth of the Global Intravascular Ultrasound Market. However, challenges such as high costs and limited awareness in developing regions may impede market expansion.

### **Intravascular Ultrasound Market End-Use Insights  **

The Global Intravascular Ultrasound Market, valued at 2.41 billion USD in 2023, showcases significant growth within the End Use segment, encompassing various healthcare settings such as Hospitals, Ambulatory Surgical Centers, and Diagnostic Laboratories. Hospitals constitute a major portion of this market, driven by the increased adoption of advanced imaging technologies for cardiovascular procedures, which enhances diagnostic accuracy and patient outcomes. Ambulatory Surgical Centers are also emerging as significant users of intravascular ultrasound due to the growing trend towards outpatient procedures and minimally invasive surgeries, allowing for reduced recovery times.

Diagnostic Laboratories play a pivotal role by providing specialized services, contributing to the accuracy and efficiency of vascular assessments. Overall, the demand for advanced imaging solutions in these end-use environments is influenced by factors such as the rising incidence of cardiovascular diseases, the need for real-time imaging during interventions, and the ongoing advancements in ultrasound technology. As the global healthcare landscape continues to evolve, the focus on precision medicine and enhanced patient care further bolsters the growth potential within the Global Intravascular Ultrasound Market.

### **Intravascular Ultrasound Market Product Type Insights  **

The Intravascular Ultrasound Market achieved a valuation of 2.41 USD Billion in 2023, reflecting a steady growth trajectory largely influenced by advancements in medical imaging technologies. The market segmentation regarding Product Type reveals significant components such as Catheters, Console Systems, and Accessories.

Catheters serve as vital tools in intravascular procedures, enhancing diagnostic and therapeutic outcomes. Console Systems are crucial for processing ultrasound images and providing essential data for healthcare professionals, thus playing a key role in surgical precision.

Accessories, while often overlooked, support the primary functions of the above-mentioned devices and contribute to the overall efficiency and effectiveness of procedures. An increasing prevalence of cardiovascular diseases, technological innovations, and patient-centric healthcare approaches fuels the demand for these products.

However, the market also faces challenges such as strict regulatory environments and high costs associated with advanced devices. Overall, the Intravascular Ultrasound Market statistics indicate robust growth, underpinned by evolving medical needs and advancements in imaging modalities.

### **Intravascular Ultrasound Market Regional Insights  **

The Intravascular Ultrasound Market revenue showcases a strong regional segmentation, with North America leading the charge, valued at 1.1 USD Billion in 2023 and projected to reach 1.7 USD Billion by 2032, highlighting its majority holding in the market due to advanced healthcare infrastructure and high adoption rates of innovative technologies. Europe follows as a significant contributor, with a valuation of 0.75 USD Billion in 2023, expected to grow to 1.15 USD Billion by 2032, driven by increasing cardiovascular diseases and a growing elderly population.

The APAC region, although smaller, shows promise with a market value of 0.45 USD Billion in 2023, growing to 0.7 USD Billion, reflecting an expanding healthcare sector and rising awareness of healthcare technologies. South America and MEA represent the lower end of the market, valued at 0.05 USD Billion and 0.06 USD Billion, respectively in 2023, reaching 0.1 USD Billion by 2032.

While their market shares are currently limited, these regions present opportunities for growth, particularly as healthcare systems evolve and access improves. This varied performance across regions underscores the Intravascular Ultrasound Market segmentation’s importance in tailoring strategies that address localized healthcare challenges and improvements.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

## **Intravascular Ultrasound Market Key Players and Competitive Insights**

The Intravascular Ultrasound Market has experienced significant growth in recent years, driven by advancements in imaging technologies and an increasing prevalence of cardiovascular diseases. Competitive insights into this market highlight the key players who are innovating and expanding their offerings, leading to improvements in diagnostic capabilities and patient care.

The market is characterized by a diverse array of products and services aimed at enhancing clinical outcomes through minimally invasive procedures. As healthcare systems globally prioritize better diagnostic tools and techniques, the competitive landscape is becoming increasingly dynamic. 

Companies are focusing on research and development, strategic partnerships, and acquisitions to solidify their position in this rapidly evolving market.GE Healthcare holds a notable position within the Global Intravascular Ultrasound Market, characterized by its robust technological capabilities and a strong emphasis on innovation.

The company is known for its advanced imaging systems that facilitate superior visualization during intravascular procedures. GE Healthcare's commitment to quality and reliability enhances its reputation among healthcare providers, enabling them to adopt its ultrasound solutions confidently. 

Furthermore, the company's extensive global distribution network provides it with a significant advantage, allowing it to cater to a wide-ranging customer base. GE Healthcare continues to invest in research and development, ensuring that its products remain at the forefront of medical technology, thereby maintaining its competitive edge in the market.

Canon Medical Systems is another formidable player in the Global Intravascular Ultrasound Market, recognized for its cutting-edge imaging technology and commitment to advancing patient care. The company's intravascular ultrasound systems are designed to provide high-resolution images that are critical for accurate diagnosis and treatment planning in cardiovascular procedures. Canon Medical Systems leverages its strong background in imaging and diagnostic solutions, ensuring that its products meet the highest standards of performance and reliability. 

The company's focus on developing user-friendly interfaces enhances the usability of its ultrasound systems, enabling healthcare professionals to adopt these advanced technologies seamlessly. Canon Medical Systems' strategic approach, combined with its investments in innovative research, positions it as a key competitor in the rapidly growing intravascular ultrasound market.

## **Key Companies in the Intravascular Ultrasound Market Include**

- GE Healthcare
- Canon Medical Systems
- Braun Melsungen
- Fujifilm
- Boston Scientific
- Medtronic
- Abbott Laboratories
- Esaote
- Nihon Kohden
- Cardiovascular Systems
- **[Philips](https://www.philips.co.in/healthcare/education-resources/technologies/igt/intravascular-ultrasound-ivus)**
- Asahi Intecc
- Terumo
- Siemens
- Endosurgical

## Intravascular Ultrasound Industry Developments

- **Q2 2024: Philips launches new IntraSight Mobile platform for intravascular ultrasound (IVUS) and iFR in the U.S.** Philips announced the U.S. launch of its IntraSight Mobile platform, designed to provide advanced intravascular ultrasound (IVUS) and iFR (instant wave-free ratio) modalities for peripheral and coronary interventions. The new system aims to improve workflow and image-guided therapy in catheterization labs.
- **Q2 2024: Boston Scientific Receives FDA Approval for Expanded Indications of the OptiCross HD IVUS Catheter** Boston Scientific announced that the U.S. FDA has approved expanded indications for its OptiCross HD Intravascular Ultrasound (IVUS) Catheter, allowing its use in additional peripheral vascular procedures beyond coronary interventions.
- **Q1 2024: Conavi Medical Announces CE Mark Approval for Novasight Hybrid IVUS-OCT Imaging System** Conavi Medical received CE Mark approval for its Novasight Hybrid System, which combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging, enabling commercialization in the European Union.
- **Q2 2024: Philips and Medtronic Announce Strategic Partnership to Advance Image-Guided Therapy Solutions** Philips and Medtronic entered a strategic partnership to integrate Philips' intravascular ultrasound (IVUS) technology with Medtronic's cardiovascular devices, aiming to enhance procedural outcomes in interventional cardiology.
- **Q1 2024: Terumo Launches Ultimaster Nagomi Drug-Eluting Stent with Integrated IVUS Guidance in Japan** Terumo Corporation launched the Ultimaster Nagomi drug-eluting stent in Japan, featuring integrated intravascular ultrasound (IVUS) guidance to optimize stent placement and improve patient outcomes.
- **Q2 2024: Boston Scientific Completes Acquisition of Baylis Medical to Expand Structural Heart and Imaging Portfolio** Boston Scientific completed its acquisition of Baylis Medical, strengthening its portfolio in structural heart interventions and intravascular imaging, including IVUS technologies.
- **Q1 2024: Infraredx, a Nipro Company, Receives FDA Clearance for Makoto Intravascular Imaging System** Infraredx, a subsidiary of Nipro Corporation, received FDA clearance for its Makoto Intravascular Imaging System, which combines IVUS and near-infrared spectroscopy (NIRS) for enhanced plaque characterization.
- **Q2 2024: Canon Medical Systems Acquires Sonomed Escalon’s Intravascular Ultrasound Business** Canon Medical Systems announced the acquisition of Sonomed Escalon’s intravascular ultrasound (IVUS) business, expanding its cardiovascular imaging portfolio.
- **Q1 2024: Philips Receives FDA Clearance for Next-Generation Eagle Eye Platinum ST IVUS Catheter** Philips received FDA clearance for its Eagle Eye Platinum ST IVUS Catheter, featuring improved deliverability and imaging performance for coronary and peripheral vascular procedures.
- **Q2 2024: Acist Medical Systems Launches New Kodama IVUS Catheter in Europe** Acist Medical Systems launched the Kodama IVUS Catheter in select European markets, offering enhanced imaging capabilities for complex coronary interventions.
- **Q1 2024: OpSens Medical Announces FDA Clearance for SavvyWire with Integrated IVUS Guidance** OpSens Medical received FDA clearance for its SavvyWire, a guidewire with integrated intravascular ultrasound (IVUS) capabilities, designed to improve precision in transcatheter aortic valve replacement (TAVR) procedures.
- **Q2 2024: Boston Scientific Launches Farapulse Pulsed Field Ablation System with IVUS Integration in Europe** Boston Scientific launched the Farapulse Pulsed Field Ablation System in Europe, featuring integration with intravascular ultrasound (IVUS) for real-time imaging during cardiac ablation procedures.

## **Intravascular Ultrasound Market Segmentation Insights**

### **Intravascular Ultrasound Market Application Outlook**

- Cardiology
- Vascular Surgery
- Oncology
- Peripheral Vascular Disease

### **Intravascular Ultrasound Market Technology Outlook**

- Standard Intravascular Ultrasound
- Radiofrequency Intravascular Ultrasound
- Optical Coherence Tomography

### **Intravascular Ultrasound Market End Use Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories

### **Intravascular Ultrasound Market Product Type Outlook**

- Catheters
- Console Systems
- Accessories

### **Intravascular Ultrasound Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### 成像技术创新

血管内超声市场正在经历技术创新的激增，这些创新增强了成像能力。先进的成像模式，如3D和4D血管内超声，提供了血管结构的详细可视化。这些创新促进了准确的诊断和治疗计划，这对介入性心脏病学至关重要。预计血管内超声系统市场在未来五年将以约8%的复合年增长率增长，这一增长受到这些进步的推动。此外，人工智能在图像分析中的整合可能会提高诊断准确性，从而增加血管内超声系统在临床环境中的采用。随着医疗服务提供者寻求改善患者结果，对这些先进成像技术在血管内超声市场中的需求预计将上升。

### 个性化医疗需求上升

个性化医疗的转变正在影响血管内超声市场。随着医疗保健的发展，越来越强调根据个体患者的特征量身定制治疗，特别是在心脏病学领域。血管内超声在这一范式中发挥着关键作用，提供实时成像，帮助评估斑块特征和血管形态。这些信息对于确定冠状动脉疾病患者最有效的治疗策略至关重要。随着医疗提供者越来越多地采用血管内超声来增强患者特定的治疗计划，市场可能会从这一趋势中受益。此外，基因组数据与成像技术的结合可能进一步细化个性化方法，从而推动未来几年对血管内超声系统的需求。

### 监管支持和报销政策

支持性的监管框架和有利的报销政策对血管内超声市场的增长至关重要。监管机构越来越认识到血管内超声在改善患者结果方面的价值，这导致新设备和技术的审批流程更加简化。此外，覆盖血管内超声程序的报销政策鼓励医疗服务提供者采用这些技术。随着对微创程序的报销变得更加标准化，患者的经济负担减轻，使血管内超声成为更可及的选择。这一趋势可能会刺激市场增长，因为医疗机构投资于先进的成像技术，以满足患者和监管标准的需求。监管支持与市场需求的对齐预计将促进血管内超声市场的扩展。

### 日益增长的意识和培训项目

对血管内超声益处的日益认识正在推动其在血管内超声市场中的采用。针对医疗专业人员的教育倡议和培训项目对于增强对这一技术的理解和利用至关重要。随着越来越多的从业者熟练掌握血管内超声技术，对这些系统的需求可能会增加。此外，专业组织和医学协会正在积极推动血管内超声在临床实践中的整合，强调其在提高诊断准确性和患者结果方面的作用。这种日益增长的认识预计将导致血管内超声作为介入心脏病学标准实践的更广泛接受。因此，培训项目和教育资源的激增预计将显著促进血管内超声市场的增长。

### 心血管疾病的发病率不断增加

心血管疾病的发病率上升是血管内超声市场的主要驱动因素。随着人口老龄化和与生活方式相关的健康问题日益普遍，对有效诊断工具的需求愈加迫切。心血管疾病仍然是全球发病率和死亡率的主要原因，迫切需要先进的成像技术以便于早期发现和干预。世界卫生组织报告称，心血管疾病约占全球所有死亡人数的31%，这突显了改善诊断解决方案的紧迫性。血管内超声提供了一种微创的方法来评估冠状动脉疾病，这可能会促进其在医疗专业人员中的采用。因此，心血管疾病的日益普遍预计将显著推动血管内超声市场的增长。

## Future Outlook

血管内超声市场预计将在2024年至2035年间以5.04%的年均增长率增长，推动因素包括技术进步、心血管疾病增加以及对微创手术需求的上升。

**New opportunities:**

- 开发基于人工智能的成像软件，以提高诊断准确性。

到2035年，血管内超声市场预计将实现显著增长和创新。

## Segment Insights

### 按应用：心脏病学（最大）与血管外科（增长最快）

在血管内超声市场中，应用细分显示出明显的份额，其中心脏病学作为最大的细分市场占据主导地位。这一突出地位归因于血管内超声技术在诊断和治疗心血管疾病中的广泛应用。尽管血管外科的份额较小，但由于手术程序的增加和成像技术的进步，正在迅速崛起。
该市场的增长趋势受到心血管疾病发病率上升以及微创手术进展的显著影响。此外，肿瘤学和外周血管疾病的应用也在获得关注，这得益于技术的改进和日益增长的老年人口，这些人群需要在这些医学领域内有效的诊断解决方案。

心脏病学（主导）与肿瘤学（新兴）

心脏病学仍然是血管内超声市场的主导应用，因为它在心血管诊断和干预中发挥着关键作用。随着医疗系统越来越强调预防护理和早期诊断，心脏病学受益于对先进成像解决方案的稳定需求。另一方面，肿瘤学是一个新兴领域，受到癌症相关血管并发症的新型诊断技术和治疗的推动。血管内超声技术的进步有望增强肿瘤检测和监测，为肿瘤学在市场中建立一个重要的细分市场。这一演变促进了更好的治疗策略，反映了医疗保健向全面癌症护理的转变。

### 按技术：标准血管内超声市场（最大）与光学相干断层扫描（增长最快）

血管内超声市场主要分为标准血管内超声市场、射频血管内超声市场和光学相干断层成像。标准血管内超声市场因其在临床环境中的广泛应用而占据市场最大份额，这得益于其在成像和指导程序中的可靠性和有效性。射频血管内超声市场以其专业应用而闻名，但市场份额较小。与此同时，光学相干断层成像虽然相对较新，但正在迅速获得关注，为该领域不断演变的竞争格局做出贡献。

技术：标准血管内超声市场（主导）与光学相干断层扫描（新兴）

标准血管内超声市场仍然是血管内超声市场中的主导技术，其特点是能够提供高分辨率、实时成像的血管结构。其在市场上的确立可以归因于其在各种临床场景中的广泛应用，导致临床医生的强烈偏好。相比之下，光学相干断层扫描作为一种强有力的替代方案正在崛起，提供了增强的分辨率和特异性的先进成像能力，使其在表征动脉斑块方面特别有用。随着对微创手术需求的增加，光学相干断层扫描有望实现显著增长，吸引投资并推动创新，从而增强其在临床实践中的应用。

### 按最终用途：医院（最大）与门诊手术中心（增长最快）

在血管内超声市场中，市场份额的分布严重倾向于医院，医院占据了整体使用的相当大比例。它们广泛的设施和对专业人员的访问使其成为血管内超声系统的主要终端用户。虽然门诊手术中心的市场份额较小，但由于对门诊手术和微创干预的日益偏好，它们正在迅速开辟自己的市场。

这一细分市场的增长趋势值得注意，尤其是门诊手术中心，需求正在激增。推动这一趋势的因素包括技术进步、患者舒适度提高以及门诊护理效率的提升。医院由于资源的可用性和综合护理服务而继续蓬勃发展，但向更快和更高效的治疗选择的转变正在将门诊手术中心推向聚光灯下。

医院（主导）与门诊手术中心（新兴）

医院在血管内超声市场中仍然是主导力量，这归因于它们在患者护理、研究和培训中的多方面角色。医院配备了先进的技术能力，提供针对复杂病例的最先进的血管内超声服务。它们建立的基础设施和广泛的专业科室使这些技术的有效整合成为可能。另一方面，门诊手术中心代表了一个新兴的细分市场，强调效率和以患者为中心的护理。这些中心受益于较低的运营成本和简化的流程，使其对寻求微创手术的患者具有吸引力。向门诊护理的日益增长的趋势与门诊手术中心的运营模式非常契合，使其在不断发展的医疗保健领域中成为一个重要参与者。

### 按产品类型：导管（最大）与控制台系统（增长最快）

在血管内超声市场中，各产品类型的市场份额分布显示导管扮演着重要角色，拥有最大的市场份额。控制台系统和配件紧随其后，但差距明显。导管的需求源于其在侵入性手术中的基本功能，显著推动了其在市场中的主导地位。尽管控制台系统目前的市场份额较小，但由于技术进步和提高手术准确性的作用，其采用率正在增加。

该细分市场的增长趋势显示，控制台系统是增长最快的组成部分。老龄化人口、心血管疾病发病率上升以及超声技术的持续创新等因素正在推动其需求。配件继续支持主要产品，但重点正转向在控制台系统中集成先进功能，突显了血管内超声市场不断演变的格局。

导管：主导系统与控制台系统：新兴

导管是血管内超声市场的主导产品类型，其在心血管手术中的诊断和干预中发挥着至关重要的作用。它们的设计注重精确性和有效性，以满足对可靠成像能力日益增长的需求。相比之下，控制台系统正在成为市场上的关键参与者，集成尖端技术以改善成像质量和工作流程效率。随着软件和用户界面设计的进步，控制台系统因其提升程序结果的潜力而受到认可。随着医疗服务提供者寻求更有效的复杂心脏干预解决方案，趋势表明逐渐向这些技术先进的系统转变，为未来的增长奠定了良好的基础。

## Regional Market Share Analysis

### 北美：创新的市场领导者

北美是血管内超声的最大市场，约占全球市场份额的45%。该地区的增长受到先进医疗基础设施、心血管疾病的日益普遍以及对研发的强烈关注的推动。来自FDA等机构的监管支持进一步促进了市场扩展，确保了创新技术和设备的可用性。

美国是该市场的领先国家，GE医疗、波士顿科学和美敦力等主要企业做出了重要贡献。尽管加拿大在市场格局中所占份额较小，但也发挥着重要作用。竞争环境的特点是主要公司之间持续的创新和战略合作，增强了整体市场动态。

### 欧洲：监管支持与增长

欧洲是血管内超声的第二大市场，约占全球市场份额的30%。该地区受益于严格的监管框架，促进高质量医疗标准。对医疗技术的投资增加以及对心血管疾病的认识提升是主要的增长驱动因素。欧盟的医疗器械法规（MDR）在确保医疗器械的安全性和有效性方面也发挥着至关重要的作用，促进了市场增长。

德国、法国和英国是该市场的领先国家，西门子医疗和飞利浦等主要企业在此有着强大的存在。竞争格局以公司之间的创新和合作为特征，增强了产品供应。该地区专注于改善患者结果和推进医疗技术，使其在未来增长中处于良好位置。

### 亚太地区：快速增长的市场

亚太地区的血管内超声市场正在迅速增长，约占全球市场份额的20%。该地区的扩展受到医疗支出增加、老年人口上升和对心血管疾病认识提高的推动。日本和中国等国在这一增长中处于领先地位，得益于政府的有利举措和对医疗基础设施的投资。

日本是该市场的重要参与者，佳能医疗系统和テルモ株式会社等主要公司为其发展做出了贡献。中国也正在成为一个关键市场，受益于庞大的患者群体和对先进医疗技术日益增长的需求。竞争格局正在演变，本地和国际参与者都在通过创新和战略合作努力争夺市场份额。

### 中东和非洲：未开发的市场潜力

中东和非洲地区在血管内超声市场中逐渐崭露头角，约占全球市场份额的5%。增长主要受到对医疗基础设施投资增加、心血管疾病的日益普遍以及对先进医疗技术关注度提高的推动。该地区的政府正在实施改善医疗服务可及性的举措，预计将进一步推动市场增长。

南非和阿联酋等国在市场中处于领先地位，主要企业的存在不断增加，并与国际公司的合作也在增加。竞争格局的特点是本地和全球公司混合，努力通过创新解决方案和战略合作增强市场存在感。随着医疗系统的不断发展，该地区的增长潜力仍然显著。

## Competitive Benchmarking

血管内超声市场目前的特点是动态竞争格局，受到技术进步和对微创手术日益增长的需求驱动。像飞利浦（荷兰）、西门子医疗（德国）和波士顿科学（美国）等主要参与者正战略性地定位自己，以利用创新并扩大市场份额。飞利浦（荷兰）专注于提升其成像技术，而西门子医疗（德国）则强调数字化转型和综合医疗解决方案。波士顿科学（美国）积极寻求合作伙伴关系，以扩大其产品供应，从而塑造一个优先考虑技术优势和全面服务交付的竞争环境。

在商业策略方面，各公司越来越多地本地化生产，以优化供应链并降低运营成本。市场似乎适度分散，多个参与者争夺市场份额。然而，像GE医疗（美国）和美敦力（美国）等大型公司的集体影响力表明，行业正朝着整合的趋势发展，因为这些公司寻求通过战略合作和资源共享来增强其竞争优势。

在2025年8月，西门子医疗（德国）宣布与一家领先的人工智能公司建立合作关系，将人工智能集成到其血管内超声系统中。这一战略举措可能会提高诊断准确性并简化工作流程，使西门子在市场上成为先进技术整合的领跑者。这一合作凸显了人工智能在医疗保健中日益重要的地位，可能为成像精度设定新的标准。

在2025年9月，波士顿科学（美国）推出了一款新的血管内超声设备，旨在改善心血管手术中的患者结果。这一产品的推出不仅反映了波士顿科学对创新的承诺，还突显了其通过满足特定临床需求来获取更大市场份额的战略。预计这一推出将增强公司在竞争中的地位，特别是在北美地区，那里对先进成像解决方案的需求正在激增。

在2025年7月，GE医疗（美国）扩大了其在亚洲的生产能力，以满足对血管内超声系统日益增长的需求。这一扩张表明GE的战略是本地化生产并提高供应链效率。通过在亚洲市场建立更强的立足点，GE医疗旨在利用该地区日益增长的医疗基础设施投资，从而巩固其竞争地位。

截至2025年10月，血管内超声市场的竞争趋势越来越多地受到数字化、可持续性和人工智能整合的定义。战略联盟在塑造市场格局中变得至关重要，各公司通过合作来增强其技术能力和市场覆盖。展望未来，竞争差异化可能会从传统的基于价格的竞争转向关注创新、先进技术和可靠的供应链，反映出医疗行业向基于价值的护理的更广泛转变。

## Recent News & Developments

- **2024年第二季度：飞利浦在美国推出新的IntraSight移动平台，用于血管内超声（IVUS）和iFR** 飞利浦宣布在美国推出其IntraSight移动平台，旨在为外周和冠状动脉介入提供先进的血管内超声（IVUS）和iFR（瞬时无波比率）模式。该新系统旨在改善导管实验室的工作流程和影像引导治疗。
- **2024年第二季度：波士顿科学获得FDA批准，扩大OptiCross HD IVUS导管的适应症** 波士顿科学宣布，美国FDA已批准其OptiCross HD血管内超声市场（IVUS）导管的适应症扩展，允许其在冠状动脉介入之外用于其他外周血管手术。
- **2024年第一季度：Conavi Medical宣布Novasight混合IVUS-OCT成像系统获得CE标志认证** Conavi Medical获得其Novasight混合系统的CE标志认证，该系统结合了血管内超声（IVUS）和光学相干断层扫描（OCT）成像，能够在欧盟进行商业化。
- **2024年第二季度：飞利浦和美敦力宣布战略合作伙伴关系，以推进影像引导治疗解决方案** 飞利浦和美敦力达成战略合作伙伴关系，将飞利浦的血管内超声（IVUS）技术与美敦力的心血管设备整合，旨在提高介入心脏病学的手术结果。
- **2024年第一季度：Terumo在日本推出集成IVUS引导的Ultimaster Nagomi药物洗脱支架** Terumo公司在日本推出了Ultimaster Nagomi药物洗脱支架，具有集成的血管内超声（IVUS）引导功能，以优化支架放置并改善患者结果。
- **2024年第二季度：波士顿科学完成收购Baylis Medical，以扩展结构性心脏和影像组合** 波士顿科学完成了对Baylis Medical的收购，增强了其在结构性心脏介入和血管内成像（包括IVUS技术）方面的组合。
- **2024年第一季度：Infraredx，Nipro公司的子公司，获得FDA对Makoto血管内成像系统的批准** Infraredx，Nipro公司的子公司，获得FDA对其Makoto血管内成像系统的批准，该系统结合了IVUS和近红外光谱（NIRS），以增强斑块特征化。
- **2024年第二季度：佳能医疗系统收购Sonomed Escalon的血管内超声市场业务** 佳能医疗系统宣布收购Sonomed Escalon的血管内超声（IVUS）业务，扩展其心血管成像组合。
- **2024年第一季度：飞利浦获得FDA对下一代Eagle Eye Platinum ST IVUS导管的批准** 飞利浦获得FDA对其Eagle Eye Platinum ST IVUS导管的批准，该导管具有改进的可输送性和成像性能，适用于冠状动脉和外周血管手术。
- **2024年第二季度：Acist医疗系统在欧洲推出新的Kodama IVUS导管** Acist医疗系统在部分欧洲市场推出Kodama IVUS导管，提供增强的成像能力，以应对复杂的冠状动脉介入。
- **2024年第一季度：OpSens医疗宣布获得FDA对SavvyWire的批准，集成IVUS引导** OpSens医疗获得FDA对其SavvyWire的批准，该导丝集成了血管内超声（IVUS）功能，旨在提高经导管主动脉瓣置换（TAVR）手术的精确度。
- **2024年第二季度：波士顿科学在欧洲推出Farapulse脉冲场消融系统，集成IVUS** 波士顿科学在欧洲推出Farapulse脉冲场消融系统，集成了血管内超声（IVUS），以在心脏消融手术中实现实时成像。

## Report Scope

| 2024年市场规模 | 2.654（十亿美元） |
| --- | --- |
| 2025年市场规模 | 2.788（十亿美元） |
| 2035年市场规模 | 4.56（十亿美元） |
| 复合年增长率（CAGR） | 5.04%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 人工智能在血管内超声市场的整合提高了诊断准确性和程序效率。 |
| 主要市场动态 | 血管内超声技术的进步推动了市场增长，并增强了心血管程序的诊断能力。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，血管内超声市场的预计市场估值是多少？**
A: 到2035年，血管内超声市场预计将达到45.6亿美元的估值。

**Q: 2024年血管内超声市场的市场估值是多少？**
A: 在2024年，血管内超声市场的市场估值为26.54亿美元。

**Q: 在2025年至2035年的预测期内，血管内超声市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，血管内超声市场的预期CAGR为5.04%。

**Q: 到2035年，哪个应用领域预计将拥有最高的估值？**
A: 心脏病学应用领域预计到2035年将达到15亿美元的估值。

**Q: 血管内超声市场的关键参与者有哪些？**
A: 血管内超声市场的主要参与者包括飞利浦、西门子医疗、GE医疗和波士顿科学。

**Q: 血管外科部门的估值在2024年到2035年之间如何变化？**
A: 血管外科部门预计将从2024年的7亿美元增长到2035年的12亿美元。

**Q: 到2035年，标准血管内超声技术的预计估值是多少？**
A: 标准血管内超声技术预计到2035年将达到18亿美元的估值。

**Q: 到2035年，预计哪个最终用途细分市场将主导市场？**
A: 医院终端使用细分市场预计将主导市场，到2035年达到22.5亿美元的估值。

**Q: 到2035年，光学相干断层扫描技术的预期增长是多少？**
A: 光学相干断层扫描技术预计将从2024年的6.54亿美元增长到2035年的12.6亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/intravascular-ultrasound-market-32654*